,reactionoutcome,reactionmeddraversionpt,reactionmeddrapt,safetyreportid
0,5,22.0,Colon cancer metastatic,16404877
0,6,22.0,Feeling abnormal,16404888
1,6,22.0,Nausea,16404888
2,6,22.0,Diarrhoea,16404888
0,3,22.0,Back pain,16404900
1,1,22.0,Rhinorrhoea,16404900
2,3,22.0,Polyneuropathy,16404900
3,3,22.0,Dysphagia,16404900
0,6,22.0,Neutrophil count decreased,16404906
0,6,22.0,Metastases to lymph nodes,16404910
1,6,22.0,Thrombocytopenia,16404910
2,6,22.0,Metastases to central nervous system,16404910
3,6,22.0,Anaemia,16404910
4,6,22.0,Neutropenia,16404910
5,6,22.0,Metastases to retroperitoneum,16404910
6,6,22.0,Bone marrow failure,16404910
7,6,22.0,Metastases to lymph nodes,16404910
0,1,22.0,Pneumonitis,16404916
0,6,22.0,Cataract,16404922
0,3,22.0,Food intolerance,16404943
1,6,22.0,Nausea,16404943
2,3,22.0,Diarrhoea,16404943
3,3,22.0,Transfusion,16404943
4,3,22.0,Weight decreased,16404943
0,3,22.0,Product availability issue,16404944
1,6,22.0,Product dose omission,16404944
2,3,22.0,Blood sodium decreased,16404944
3,3,22.0,Pollakiuria,16404944
4,3,22.0,Blood urine,16404944
0,6,22.0,Malignant neoplasm progression,16404954
1,6,22.0,Pleural effusion,16404954
2,2,22.0,Radiation pneumonitis,16404954
0,5,22.0,Thoracic haemorrhage,16405023
0,6,22.0,Nasopharyngitis,16405029
1,6,22.0,Product use in unapproved indication,16405029
2,6,22.0,Off label use,16405029
3,6,22.0,Influenza,16405029
0,5,22.0,Acute respiratory distress syndrome,16405035
1,5,22.0,Nosocomial infection,16405035
2,5,22.0,Cardiopulmonary failure,16405035
0,6,22.0,Injection site pain,16405036
1,3,22.0,Injection site discomfort,16405036
2,2,22.0,Leukopenia,16405036
3,1,22.0,Platelet count increased,16405036
4,6,22.0,Neutropenia,16405036
0,5,22.0,Death,16405038
0,6,22.0,Osteonecrosis of jaw,16405059
0,6,22.0,Haematotoxicity,16405068
1,6,22.0,Nausea,16405068
2,6,22.0,Stomatitis,16405068
0,5,22.0,Pulmonary haemorrhage,16405079
1,5,22.0,Acute respiratory distress syndrome,16405079
0,1,22.0,Aspartate aminotransferase increased,16405088
1,1,22.0,Alanine aminotransferase increased,16405088
0,6,22.0,Drug interaction,16405125
1,6,22.0,Drug ineffective,16405125
0,6,22.0,Bone marrow failure,16405126
1,3,22.0,Febrile neutropenia,16405126
0,6,22.0,Drug interaction,16405133
1,2,22.0,Malignant neoplasm progression,16405133
2,2,22.0,Fatigue,16405133
3,2,22.0,Dysgeusia,16405133
4,2,22.0,Diarrhoea,16405133
0,1,22.0,Abdominal pain,16405142
0,6,22.0,White blood cell count decreased,16405153
1,6,22.0,Carbohydrate antigen 15-3 increased,16405153
2,6,22.0,Neutropenia,16405153
0,6,22.0,Product use in unapproved indication,16405187
1,5,22.0,Death,16405187
0,2,22.0,Vomiting,16405238
1,3,22.0,Blood pressure decreased,16405238
2,2,22.0,Rash erythematous,16405238
3,2,22.0,Cold sweat,16405238
0,6,22.0,Skin burning sensation,16405247
1,6,22.0,Mood swings,16405247
2,6,22.0,Blister,16405247
3,6,22.0,Decreased appetite,16405247
4,6,22.0,Weight decreased,16405247
5,6,22.0,Hot flush,16405247
6,6,22.0,Vomiting,16405247
0,3,22.0,Diarrhoea,16405333
1,1,22.0,Pancreatitis,16405333
2,1,22.0,Blood thyroid stimulating hormone increased,16405333
3,3,22.0,Abdominal pain upper,16405333
4,1,22.0,Decreased appetite,16405333
5,3,22.0,Muscle spasms,16405333
0,1,22.0,Abdominal pain upper,16405347
1,3,22.0,Constipation,16405347
2,1,22.0,Intestinal obstruction,16405347
3,6,22.0,Fatigue,16405347
4,6,22.0,Platelet count decreased,16405347
5,3,22.0,Vomiting,16405347
6,1,22.0,Hernia,16405347
7,3,22.0,Nausea,16405347
8,1,22.0,Decreased appetite,16405347
0,2,22.0,Blood creatine phosphokinase increased,16405413
0,1,22.0,Infusion related reaction,16405414
1,1,22.0,Shock,16405414
2,1,22.0,Hyperhidrosis,16405414
3,1,22.0,Low cardiac output syndrome,16405414
4,1,22.0,Cardiac failure,16405414
0,6,22.0,Abdominal pain upper,16405416
1,2,22.0,Arthralgia,16405416
2,6,22.0,Cyanosis,16405416
3,6,22.0,Oxygen saturation decreased,16405416
4,6,22.0,Heart rate increased,16405416
5,6,22.0,Blood pressure decreased,16405416
6,6,22.0,Nausea,16405416
7,2,22.0,Vomiting,16405416
8,6,22.0,Hyperhidrosis,16405416
0,1,22.0,Bone marrow failure,16405423
0,2,22.0,Renal impairment,16405457
1,1,22.0,Tubulointerstitial nephritis,16405457
0,2,22.0,Bone marrow failure,16405533
0,6,22.0,Bone marrow failure,16405543
0,6,22.0,Rheumatoid arthritis,16405550
0,5,22.0,Death,16405551
1,6,22.0,Adverse event,16405551
2,6,22.0,Product use in unapproved indication,16405551
0,3,22.1,Depression,16405579
1,3,22.1,Cognitive disorder,16405579
2,6,22.1,Muscle spasms,16405579
3,3,22.1,Visual impairment,16405579
4,3,22.1,Tinnitus,16405579
5,3,22.1,Dysstasia,16405579
6,3,22.1,Emotional disorder,16405579
7,3,22.1,Insomnia,16405579
8,3,22.1,Impaired work ability,16405579
9,3,22.1,Disturbance in attention,16405579
10,3,22.1,Radiation neuropathy,16405579
11,3,22.1,Tetany,16405579
12,3,22.1,Hallucination,16405579
13,3,22.1,Neuropathy peripheral,16405579
14,6,22.1,Blister,16405579
15,6,22.1,Burning sensation,16405579
16,6,22.1,Paraesthesia,16405579
17,3,22.1,Facial pain,16405579
18,3,22.1,Gait disturbance,16405579
19,3,22.1,Pain,16405579
20,3,22.1,Muscle contracture,16405579
21,3,22.1,Quality of life decreased,16405579
22,6,22.1,Vomiting,16405579
23,6,22.1,Weight increased,16405579
24,6,22.1,Xerosis,16405579
25,3,22.1,Pain in extremity,16405579
26,3,22.1,Fatigue,16405579
27,3,22.1,Hot flush,16405579
28,3,22.1,Myalgia,16405579
29,3,22.1,Neuromuscular pain,16405579
30,3,22.1,Neuralgia,16405579
31,6,22.1,Arthralgia,16405579
32,6,22.1,Ageusia,16405579
0,6,22.0,Monoplegia,16405590
1,6,22.0,Hypoacusis,16405590
0,5,22.0,Death,16405638
0,1,22.0,Febrile neutropenia,16405641
0,5,22.0,Malignant neoplasm progression,16405656
0,1,22.0,Thrombocytopenia,16405659
1,1,22.0,Febrile neutropenia,16405659
2,1,22.0,Neutropenia,16405659
3,1,22.0,Anaemia,16405659
0,1,22.1,Anaemia,16405660
1,1,22.1,Thrombocytopenia,16405660
2,1,22.1,Neutropenia,16405660
3,1,22.1,Febrile neutropenia,16405660
0,3,22.0,Pneumonia,16405676
0,3,22.0,Prostatic specific antigen increased,16405777
0,1,22.0,Anaemia,16405879
1,1,22.0,Pyrexia,16405879
0,1,22.0,Rhinorrhoea,16405899
1,3,22.0,Tachycardia,16405899
2,3,22.0,Asthenia,16405899
3,1,22.0,Anaemia,16405899
4,1,22.0,Teeth brittle,16405899
5,1,22.0,Musculoskeletal stiffness,16405899
6,3,22.0,Urge incontinence,16405899
7,3,22.0,Decreased appetite,16405899
8,3,22.0,Orthostatic hypotension,16405899
9,1,22.0,Constipation,16405899
10,1,22.0,Depressed mood,16405899
11,1,22.0,Epistaxis,16405899
12,1,22.0,Muscle spasms,16405899
13,1,22.0,Tinnitus,16405899
14,1,22.0,Dry skin,16405899
15,3,22.0,Dysphonia,16405899
16,1,22.0,Hyperkeratosis,16405899
17,3,22.0,Balance disorder,16405899
18,1,22.0,Neutropenia,16405899
19,1,22.0,Visual impairment,16405899
20,1,22.0,Contusion,16405899
21,3,22.0,Dizziness,16405899
22,1,22.0,Alopecia,16405899
23,3,22.0,Myalgia,16405899
24,3,22.0,Gastrooesophageal reflux disease,16405899
0,6,22.0,Product use in unapproved indication,16405909
1,6,22.0,Delirium,16405909
0,6,22.0,Eosinophil count increased,16405919
0,3,22.1,Invasive ductal breast carcinoma,16405920
0,1,22.0,Vomiting,16405927
1,1,22.0,Nausea,16405927
2,2,22.0,Neuropathy peripheral,16405927
3,1,22.0,Mucosal inflammation,16405927
4,1,22.0,Tachycardia,16405927
5,1,22.0,Erysipelas,16405927
6,1,22.0,Dizziness,16405927
0,1,22.0,Cardiac arrest,16405966
1,1,22.0,Anaphylactic reaction,16405966
0,6,22.0,Cardiac failure,16405976
0,5,22.0,Death,16405978
0,1,22.0,Mental status changes,16405981
0,5,22.0,Drug-induced liver injury,16406000
1,5,22.0,Blood bilirubin increased,16406000
2,5,22.0,Coma hepatic,16406000
3,5,22.0,Hepatic function abnormal,16406000
4,5,22.0,Pyrexia,16406000
5,,22.0,Intentional product use issue,16406000
6,5,22.0,Jaundice,16406000
7,5,22.0,Hepatic failure,16406000
8,5,22.0,Depressed level of consciousness,16406000
0,3,22.1,Alopecia,16406013
1,3,22.1,Hair colour changes,16406013
2,3,22.1,Hair disorder,16406013
3,3,22.1,Hair texture abnormal,16406013
4,3,22.1,Madarosis,16406013
0,3,22.0,Alopecia,16406020
1,6,22.0,Hair disorder,16406020
2,6,22.0,Hair texture abnormal,16406020
3,6,22.0,Hair colour changes,16406020
0,3,22.0,Madarosis,16406022
1,3,22.0,Hair disorder,16406022
2,3,22.0,Hair texture abnormal,16406022
3,3,22.0,Hair colour changes,16406022
4,3,22.0,Alopecia,16406022
0,6,22.1,Fatigue,16406025
0,6,22.1,Sleep apnoea syndrome,16406028
1,6,22.1,Fatigue,16406028
2,6,22.1,Somnolence,16406028
3,3,22.1,Arthralgia,16406028
4,6,22.1,Snoring,16406028
5,6,22.1,Chronic obstructive pulmonary disease,16406028
6,6,22.1,Arthropathy,16406028
7,6,22.1,Cough,16406028
0,3,22.0,Alopecia,16406029
1,3,22.0,Hair texture abnormal,16406029
2,3,22.0,Madarosis,16406029
3,3,22.0,Hair colour changes,16406029
4,3,22.0,Hair disorder,16406029
0,3,22.0,Alopecia,16406031
1,3,22.0,Hair disorder,16406031
2,3,22.0,Hair colour changes,16406031
3,3,22.0,Madarosis,16406031
4,3,22.0,Hair texture abnormal,16406031
0,2,22.0,Alopecia,16406034
0,6,22.0,Vision blurred,16406040
1,6,22.0,Vitreous floaters,16406040
0,6,22.0,Eye disorder,16406041
1,6,22.0,Fatigue,16406041
0,6,22.0,Diarrhoea,16406043
0,3,22.0,Decubitus ulcer,16406130
1,2,22.0,Dermal cyst,16406130
2,,22.0,General physical health deterioration,16406130
3,3,22.0,Rash,16406130
4,,22.0,Hepatic failure,16406130
5,,22.0,Off label use,16406130
6,,22.0,Scrotal ulcer,16406130
7,3,22.0,Gastrooesophageal reflux disease,16406130
0,6,22.0,Chromaturia,16406254
1,6,22.0,Hypokalaemia,16406254
2,6,22.0,Face oedema,16406254
3,6,22.0,Oedema peripheral,16406254
4,6,22.0,Skin oedema,16406254
5,6,22.0,Hepatic function abnormal,16406254
0,6,22.0,Metastases to spine,16406286
1,6,22.0,Metastasis,16406286
2,2,22.0,Dengue fever,16406286
3,6,22.0,Malignant neoplasm progression,16406286
0,1,22.0,Prostatitis,16406298
1,6,22.0,Immunodeficiency,16406298
2,6,22.0,Respiratory tract infection,16406298
3,1,22.0,Vomiting,16406298
4,6,22.0,Nasopharyngitis,16406298
5,1,22.0,Pyelitis,16406298
0,2,22.0,Vomiting,16406299
1,2,22.0,Rash erythematous,16406299
2,3,22.0,Blood pressure decreased,16406299
3,2,22.0,Cold sweat,16406299
0,1,22.0,Hypokalaemia,16406307
1,2,22.0,Malnutrition,16406307
2,6,22.0,Hypertension,16406307
3,5,22.0,General physical health deterioration,16406307
4,6,22.0,Brain oedema,16406307
5,6,22.0,Constipation,16406307
6,1,22.0,Dehydration,16406307
7,6,22.0,Metastases to central nervous system,16406307
8,1,22.0,Hyponatraemia,16406307
0,6,22.0,No adverse event,16406316
1,6,22.0,Product dose omission,16406316
2,6,22.0,Product supply issue,16406316
3,6,22.0,Circumstance or information capable of leading to medication error,16406316
0,6,22.0,Enteritis,16406321
1,6,22.0,Metastases to pleura,16406321
2,2,22.0,Chest pain,16406321
0,,22.0,Hospitalisation,16406345
1,,22.0,Gastrointestinal obstruction,16406345
0,1,22.1,Pyrexia,16406357
1,1,22.1,Renal impairment,16406357
2,1,22.1,Anaemia,16406357
3,1,22.1,Malaise,16406357
4,1,22.1,Taste disorder,16406357
5,1,22.1,Rash,16406357
6,1,22.1,Somnolence,16406357
7,1,22.1,Sinusitis,16406357
0,6,22.0,Coagulation test abnormal,16406358
1,1,22.0,Haematuria,16406358
2,6,22.0,Off label use,16406358
3,6,22.0,Product use in unapproved indication,16406358
0,6,22.0,Urinary tract infection,16406364
1,6,22.0,Oropharyngeal pain,16406364
2,6,22.0,Weight decreased,16406364
3,6,22.0,Blister,16406364
0,3,22.0,IIIrd nerve paralysis,16406378
0,1,22.1,Cough,16406405
1,1,22.1,Hypersensitivity,16406405
2,1,22.1,Erythema,16406405
3,1,22.1,Sense of oppression,16406405
0,3,22.0,Pain,16406425
1,5,22.0,Malignant neoplasm progression,16406425
2,3,22.0,Hypophagia,16406425
3,6,22.0,Drug abuse,16406425
4,6,22.0,Product use in unapproved indication,16406425
5,3,22.0,Abdominal pain,16406425
6,6,22.0,Drug dependence,16406425
7,3,22.0,Ascites,16406425
8,6,22.0,Drug ineffective,16406425
9,5,22.0,Metastatic gastric cancer,16406425
10,6,22.0,Nausea,16406425
11,3,22.0,Vomiting,16406425
12,6,22.0,Overdose,16406425
13,6,22.0,Ileus paralytic,16406425
0,3,22.1,Hypertension,16406428
1,1,22.1,Hypokalaemia,16406428
2,1,22.1,Pulmonary oedema,16406428
3,3,22.1,Taste disorder,16406428
4,3,22.1,Sinusitis,16406428
5,1,22.1,Nasopharyngitis,16406428
6,1,22.1,Respiratory failure,16406428
7,1,22.1,Alopecia,16406428
8,1,22.1,Peripheral sensory neuropathy,16406428
9,3,22.1,Nasal dryness,16406428
10,3,22.1,Myalgia,16406428
11,1,22.1,Malignant pleural effusion,16406428
12,1,22.1,Abdominal hernia,16406428
13,1,22.1,Diarrhoea,16406428
14,3,22.1,Muscle spasms,16406428
15,3,22.1,Fatigue,16406428
16,3,22.1,Decreased appetite,16406428
0,6,22.0,Hypertension,16406441
1,6,22.0,Arthralgia,16406441
2,6,22.0,Nausea,16406441
3,6,22.0,Bone pain,16406441
4,6,22.0,Decreased appetite,16406441
5,6,22.0,Pancreatitis,16406441
6,6,22.0,Fatigue,16406441
0,6,22.1,Dementia,16406443
1,5,22.1,Death,16406443
0,3,22.0,Rectal adenocarcinoma,16406446
1,3,22.0,Second primary malignancy,16406446
0,6,22.0,Ascites,16406455
1,6,22.0,Dyspnoea,16406455
2,6,22.0,Neutropenia,16406455
3,6,22.0,Thrombocytopenia,16406455
0,1,22.0,Skin exfoliation,16406466
1,1,22.0,Xerosis,16406466
2,1,22.0,Eczema,16406466
0,3,22.0,Spinal fracture,16406468
1,6,22.0,Inappropriate schedule of product administration,16406468
0,5,22.1,Malignant neoplasm progression,16406477
1,3,22.1,Platelet count decreased,16406477
0,5,22.0,Hypertransaminasaemia,16406489
1,5,22.0,Hyperammonaemic encephalopathy,16406489
2,5,22.0,Hyperbilirubinaemia,16406489
3,5,22.0,Hepatic failure,16406489
0,2,22.0,Rheumatoid arthritis,16406504
0,4,22.0,Tendon rupture,16406505
0,3,22.0,Abdominal pain upper,16406514
1,1,22.0,Condition aggravated,16406514
2,1,22.0,Gastroenteritis radiation,16406514
0,1,22.1,Diarrhoea,16406521
1,6,22.1,Nocturnal dyspnoea,16406521
0,1,22.0,Pancreatitis,16406523
0,6,22.0,Second primary malignancy,16406586
1,6,22.0,Acute myeloid leukaemia,16406586
0,6,22.0,Diarrhoea,16406612
1,6,22.0,Haematotoxicity,16406612
2,6,22.0,Stomatitis,16406612
0,6,22.0,Coronary artery disease,16406615
0,6,22.0,Thrombosis,16406622
0,6,22.0,Metastases to the mediastinum,16406661
1,6,22.0,Malignant neoplasm progression,16406661
2,6,22.0,Metastases to liver,16406661
3,6,22.0,Breast cancer,16406661
0,6,22.0,Fracture,16406665
1,6,22.0,Dizziness,16406665
2,6,22.0,Blood potassium decreased,16406665
3,6,22.0,Fall,16406665
0,1,22.1,Pneumocystis jirovecii pneumonia,16406669
0,5,22.1,Malignant neoplasm progression,16406681
1,6,22.1,Drug ineffective,16406681
0,1,22.0,Nausea,16406686
1,1,22.0,Anaemia,16406686
2,5,22.0,Respiratory failure,16406686
3,1,22.0,Vomiting,16406686
4,2,22.0,Sepsis,16406686
0,2,22.0,Injection site pain,16406745
1,2,22.0,Injection site swelling,16406745
2,6,22.0,Product use in unapproved indication,16406745
3,1,22.0,Decreased appetite,16406745
4,6,22.0,Off label use,16406745
5,2,22.0,Injection site erythema,16406745
0,5,22.0,Death,16406757
0,5,22.0,Death,16406759
0,3,22.0,Immune-mediated adverse reaction,16406772
1,6,22.0,Hyperthyroidism,16406772
2,3,22.0,Silent thyroiditis,16406772
3,6,22.0,Primary hypothyroidism,16406772
4,5,22.0,Malignant neoplasm progression,16406772
0,6,22.0,Hyperthyroidism,16406776
1,3,22.0,Silent thyroiditis,16406776
2,3,22.0,Immune-mediated adverse reaction,16406776
3,6,22.0,Primary hypothyroidism,16406776
0,,22.0,Retinopathy,16406827
0,3,22.0,Diarrhoea,16406890
0,5,22.0,Death,16406903
1,6,22.0,Intentional product use issue,16406903
0,2,22.0,Stoma site inflammation,16406951
1,3,22.0,Paronychia,16406951
2,6,22.0,Metastases to liver,16406951
3,3,22.0,Hepatic function abnormal,16406951
0,6,22.0,Surgery,16407007
1,6,22.0,Off label use,16407007
2,1,22.0,Pneumonitis,16407007
0,1,22.0,Feeling cold,16407126
1,1,22.0,Hyperpyrexia,16407126
0,1,22.1,Pneumonitis,16407135
1,1,22.1,Mucosal inflammation,16407135
2,1,22.1,Diarrhoea,16407135
0,6,22.0,Malignant neoplasm progression,16407142
1,6,22.0,Atrial fibrillation,16407142
2,6,22.0,Back pain,16407142
3,6,22.0,Decreased appetite,16407142
4,6,22.0,Lymphocyte count decreased,16407142
5,6,22.0,Vomiting,16407142
6,6,22.0,Clostridium test positive,16407142
7,6,22.0,Sinus tachycardia,16407142
8,6,22.0,Tumour ulceration,16407142
9,6,22.0,Pneumonia,16407142
10,6,22.0,Abdominal pain,16407142
11,6,22.0,Leukocytosis,16407142
12,6,22.0,Abdominal distension,16407142
13,6,22.0,Hypoalbuminaemia,16407142
14,6,22.0,Nausea,16407142
15,6,22.0,Tumour haemorrhage,16407142
16,6,22.0,Hypocalcaemia,16407142
17,6,22.0,Atelectasis,16407142
18,6,22.0,Oedema,16407142
19,6,22.0,Pleural effusion,16407142
0,6,22.0,Loss of consciousness,16407158
1,6,22.0,Diarrhoea,16407158
0,6,22.0,Pancreatic carcinoma,16407161
0,3,22.0,Dermatitis psoriasiform,16407163
0,3,22.0,Diarrhoea,16407170
1,3,22.0,Fungal infection,16407170
2,3,22.0,Decreased appetite,16407170
0,5,22.0,Death,16407219
0,6,22.0,Lipoma,16407232
1,6,22.0,Hypertension,16407232
2,6,22.0,Localised infection,16407232
3,6,22.0,Protein urine present,16407232
4,6,22.0,Weight decreased,16407232
5,6,22.0,Renal impairment,16407232
6,6,22.0,Blood creatinine increased,16407232
0,3,22.0,Pain,16407267
1,3,22.0,Palliative care,16407267
0,2,22.0,Fall,16407330
1,2,22.0,Wrong product administered,16407330
2,2,22.0,Dehydration,16407330
0,2,22.0,Bladder cancer recurrent,16407374
1,6,22.0,Incorrect route of product administration,16407374
0,3,22.0,Intentional product misuse,16407418
1,3,22.0,Dysgeusia,16407418
0,2,22.0,Liver function test increased,16407421
0,1,22.0,Dehydration,16407466
1,1,22.0,Hypokalaemia,16407466
2,1,22.0,Diarrhoea,16407466
3,1,22.0,Leukopenia,16407466
4,1,22.0,Pneumonia,16407466
5,2,22.0,Oedema,16407466
0,1,22.0,Osteonecrosis of jaw,16407467
1,6,22.0,Chronic sinusitis,16407467
2,4,22.0,Osteonecrosis of jaw,16407467
3,1,22.0,Acute sinusitis,16407467
4,4,22.0,Acute sinusitis,16407467
5,6,22.0,Condition aggravated,16407467
0,1,22.0,Neutropenic sepsis,16407472
1,1,22.0,Pyrexia,16407472
2,1,22.0,Rash,16407472
0,1,22.0,Diarrhoea,16407473
1,1,22.0,Blood phosphorus decreased,16407473
2,3,22.0,Decreased appetite,16407473
3,1,22.0,Vomiting,16407473
4,3,22.0,Nausea,16407473
0,3,22.0,Acute abdomen,16407475
0,2,22.1,Fatigue,16407536
1,6,22.1,Fluid retention,16407536
0,6,22.0,Flatulence,16407538
1,6,22.0,Diarrhoea,16407538
0,6,22.0,Off label use,16407553
1,2,22.0,Oedema peripheral,16407553
2,2,22.0,Diarrhoea,16407553
3,6,22.0,Incorrect dose administered,16407553
4,2,22.0,Fatigue,16407553
0,1,22.0,Urticaria,16407564
1,1,22.0,Infusion related reaction,16407564
0,1,22.1,Vomiting,16407588
1,1,22.1,Hypokalaemia,16407588
2,1,22.1,Diarrhoea,16407588
3,1,22.1,Nausea,16407588
0,6,22.0,Decreased appetite,16407617
1,6,22.0,Malaise,16407617
2,6,22.0,Malignant neoplasm progression,16407617
3,6,22.0,Toxicity to various agents,16407617
4,6,22.0,Abdominal discomfort,16407617
5,6,22.0,Breast cancer metastatic,16407617
6,6,22.0,Intestinal metastasis,16407617
7,6,22.0,Nausea,16407617
0,6,22.0,Fatigue,16407637
1,6,22.0,Hypothyroidism,16407637
0,1,22.0,Diarrhoea,16407675
1,1,22.0,Dehydration,16407675
2,1,22.0,Loss of consciousness,16407675
3,1,22.0,Dysgeusia,16407675
4,1,22.0,Myalgia,16407675
5,1,22.0,Sinus operation,16407675
0,6,22.0,Failure to anastomose,16407696
1,6,22.0,Hypersensitivity,16407696
2,6,22.0,Vomiting,16407696
0,1,22.0,Hyperglycaemia,16407716
1,1,22.0,Blood creatinine increased,16407716
0,6,22.0,Renal impairment,16407718
1,6,22.0,Liver injury,16407718
0,1,22.0,Chest discomfort,16407752
1,1,22.0,Urticaria,16407752
2,1,22.0,Pruritus,16407752
0,6,22.0,Hospitalisation,16407841
1,5,22.0,Death,16407841
0,2,22.0,Blood pressure increased,16407906
1,2,22.0,Hot flush,16407906
0,2,22.0,Malignant neoplasm progression,16408021
0,5,22.1,Gas gangrene,16408056
0,1,22.0,Erythema multiforme,16408081
0,6,22.0,Lung disorder,16408087
0,2,22.1,Hepatic function abnormal,16408107
1,1,22.1,Haemophagocytic lymphohistiocytosis,16408107
0,6,22.0,Osteoma cutis,16408130
0,6,22.0,Anaphylactic reaction,16408143
1,6,22.0,Swelling,16408143
2,6,22.0,Generalised erythema,16408143
3,3,22.0,Rash generalised,16408143
0,6,22.0,Intestinal obstruction,16408150
0,6,22.0,Disease progression,16408155
1,6,22.0,Colon cancer,16408155
2,6,22.0,Diarrhoea,16408155
0,2,22.0,Infection,16408156
1,6,22.0,Inflammation,16408156
2,2,22.0,Intestinal obstruction,16408156
3,2,22.0,White blood cell count decreased,16408156
4,2,22.0,Platelet count decreased,16408156
5,2,22.0,Protein urine present,16408156
6,2,22.0,Red blood cell count decreased,16408156
7,2,22.0,Hypocalcaemia,16408156
8,2,22.0,Pyrexia,16408156
0,2,22.1,Weight increased,16408159
1,2,22.1,Cough,16408159
2,4,22.1,Lower respiratory tract infection,16408159
3,4,22.1,Dyspnoea,16408159
4,6,22.1,Pneumonia,16408159
0,3,22.0,Myalgia,16408164
1,3,22.0,Bone pain,16408164
0,1,22.0,Rash generalised,16408173
0,6,22.0,Atrial fibrillation,16408175
0,6,22.0,Gastrointestinal anastomotic leak,16408185
0,6,22.0,Drug ineffective,16408186
0,6,22.0,Proteinuria,16408256
1,6,22.0,Gastrointestinal haemorrhage,16408256
2,6,22.0,Arthralgia,16408256
3,6,22.0,Joint range of motion decreased,16408256
4,6,22.0,Musculoskeletal pain,16408256
5,6,22.0,Gastrointestinal perforation,16408256
6,6,22.0,Hypertension,16408256
7,6,22.0,Respiratory tract haemorrhage,16408256
8,6,22.0,Embolism,16408256
9,6,22.0,Wound complication,16408256
0,3,22.0,Gait inability,16408263
1,6,22.0,Pain in extremity,16408263
2,6,22.0,Back pain,16408263
0,5,22.0,Malignant neoplasm progression,16408292
1,6,22.0,Oxygen therapy,16408292
2,6,22.0,Adverse event,16408292
0,6,22.0,Bone marrow failure,16408339
1,6,22.0,Gastrointestinal disorder,16408339
2,1,22.0,Platelet aggregation inhibition,16408339
0,6,22.0,Unintentional medical device removal,16408357
1,6,22.0,Wrong technique in product usage process,16408357
0,2,22.0,Rash erythematous,16408406
1,3,22.0,Blood pressure decreased,16408406
2,2,22.0,Vomiting,16408406
3,2,22.0,Cold sweat,16408406
0,1,22.0,Lung disorder,16408541
0,6,22.0,Bone marrow failure,16408545
1,6,22.0,Gastrointestinal disorder,16408545
0,6,22.0,Arthralgia,16408551
1,1,22.0,Rheumatoid arthritis,16408551
0,6,22.0,Liver disorder,16408608
1,6,22.0,Cardiac disorder,16408608
2,6,22.0,Colon neoplasm,16408608
0,6,22.0,Gastrointestinal disorder,16408609
1,6,22.0,Hepatic function abnormal,16408609
2,6,22.0,Intestinal obstruction,16408609
3,6,22.0,White blood cell count decreased,16408609
0,3,22.0,Glomerulonephritis,16408612
1,3,22.0,Chronic kidney disease,16408612
2,3,22.0,Febrile neutropenia,16408612
0,1,22.0,Cardiotoxicity,16408628
0,2,22.0,Visual acuity reduced,16408629
1,6,22.0,Cataract,16408629
2,2,22.0,Corneal disorder,16408629
0,1,22.0,Skin disorder,16408718
1,1,22.0,Eosinophilia,16408718
2,6,22.0,White blood cell count abnormal,16408718
3,6,22.0,Eosinophilic pleural effusion,16408718
4,6,22.0,Inappropriate schedule of product administration,16408718
0,2,22.0,Pneumonitis,16408729
0,6,22.0,Terminal state,16408751
0,6,22.0,Rash,16408913
1,6,22.0,Drug hypersensitivity,16408913
2,6,22.0,Jaundice cholestatic,16408913
0,1,22.0,Spinal compression fracture,16408934
0,6,22.0,Metastases to liver,16408952
1,6,22.0,Metastases to the mediastinum,16408952
2,6,22.0,Malignant neoplasm progression,16408952
3,6,22.0,Breast cancer,16408952
0,5,22.0,Death,16408999
0,5,22.0,Pneumocystis jirovecii pneumonia,16409024
1,5,22.0,Respiratory failure,16409024
0,5,22.0,Pneumocystis jirovecii pneumonia,16409025
1,6,22.0,Off label use,16409025
2,5,22.0,Respiratory failure,16409025
3,5,22.0,Drug ineffective,16409025
0,2,22.0,Thrombocytopenic purpura,16409037
0,1,22.0,Hypersensitivity,16409039
1,1,22.0,Coma,16409039
2,1,22.0,Seizure,16409039
0,1,22.1,Hypertrichosis,16409043
1,1,22.1,Nausea,16409043
2,1,22.1,Rash,16409043
3,1,22.1,Herpes simplex,16409043
4,3,22.1,Neuropathy peripheral,16409043
5,6,22.1,Haematotoxicity,16409043
6,1,22.1,Epistaxis,16409043
7,1,22.1,Anaemia,16409043
8,6,22.1,Stomatitis,16409043
9,1,22.1,Thrombocytopenia,16409043
0,1,22.0,Asthenia,16409053
1,1,22.0,Hypercreatinaemia,16409053
2,1,22.0,Leukocytosis,16409053
3,1,22.0,Proteinuria,16409053
4,1,22.0,Weight decreased,16409053
5,1,22.0,Decreased appetite,16409053
6,1,22.0,Gait disturbance,16409053
7,1,22.0,Neutrophilia,16409053
8,1,22.0,Dyspnoea,16409053
0,6,22.0,Syncope,16409060
1,6,22.0,Depressed level of consciousness,16409060
2,6,22.0,Abdominal pain upper,16409060
0,1,22.0,Peripheral swelling,16409076
1,2,22.0,Rash generalised,16409076
2,1,22.0,Joint swelling,16409076
3,1,22.0,Fatigue,16409076
0,6,22.0,Application site exfoliation,16409193
1,6,22.0,Urinary tract obstruction,16409193
0,6,22.0,Stomatitis,16409209
1,6,22.0,Bone marrow failure,16409209
2,6,22.0,Platelet count decreased,16409209
3,6,22.0,Palmar-plantar erythrodysaesthesia syndrome,16409209
4,6,22.0,Vomiting,16409209
0,5,22.0,Disseminated intravascular coagulation,16409284
0,1,22.1,Urinary tract infection,16409385
1,1,22.1,Hypokalaemia,16409385
0,6,22.0,Hypertrichosis,16409394
1,6,22.0,Thrombocytopenia,16409394
2,6,22.0,Dermatitis acneiform,16409394
3,6,22.0,Epistaxis,16409394
4,6,22.0,Neuropathy peripheral,16409394
5,6,22.0,Haematotoxicity,16409394
6,6,22.0,Anaemia,16409394
7,6,22.0,Herpes simplex,16409394
8,6,22.0,Nausea,16409394
9,6,22.0,Stomatitis,16409394
0,6,22.0,Syncope,16409395
1,6,22.0,Confusional state,16409395
2,2,22.0,Posterior reversible encephalopathy syndrome,16409395
0,5,22.0,Rash generalised,16409396
1,5,22.0,Disease progression,16409396
0,2,22.0,Hyperthyroidism,16409402
1,2,22.0,Thyroiditis,16409402
0,2,22.0,Fatigue,16409416
0,2,22.1,Neutropenia,16409493
0,6,22.0,Rash,16409497
0,1,22.0,Neutropenia,16409518
1,6,22.0,Off label use,16409518
2,1,22.0,Anaemia,16409518
3,1,22.0,Pyrexia,16409518
4,1,22.0,Thrombocytopenia,16409518
5,1,22.0,Urinary tract infection,16409518
0,6,22.1,Stoma site haemorrhage,16409600
1,2,22.1,Gastrointestinal haemorrhage,16409600
2,6,22.1,Drug interaction,16409600
0,5,22.0,Respiratory failure,16409712
1,5,22.0,Pneumocystis jirovecii pneumonia,16409712
0,1,22.0,Blister,16409776
1,3,22.0,Nausea,16409776
2,6,22.0,Memory impairment,16409776
3,3,22.0,White blood cell count decreased,16409776
4,1,22.0,Lip blister,16409776
0,6,22.1,Arthropod bite,16409796
1,1,22.1,Hypersensitivity,16409796
0,2,22.1,White blood cell count decreased,16409814
1,6,22.1,Pain,16409814
2,2,22.1,Pneumonia viral,16409814
3,3,22.1,Malaise,16409814
0,6,22.0,Neoplasm progression,16409815
0,1,22.0,White blood cell count decreased,16409845
0,2,22.0,Pain,16409886
0,5,22.0,Cerebral haemorrhage,16409944
0,2,22.0,Intestinal obstruction,16409949
0,1,22.0,Aortitis,16409965
1,6,22.0,Febrile neutropenia,16409965
2,6,22.0,Dehydration,16409965
3,6,22.0,Diarrhoea,16409965
4,6,22.0,Syncope,16409965
0,3,22.0,Weight decreased,16409984
1,3,22.0,Hospitalisation,16409984
2,,22.0,Blister,16409984
3,,22.0,Off label use,16409984
4,3,22.0,Skin disorder,16409984
5,1,22.0,Fall,16409984
6,3,22.0,Product use issue,16409984
7,,22.0,Sunburn,16409984
8,,22.0,Product dose omission,16409984
9,,22.0,Thermal burn,16409984
0,6,22.0,Hip fracture,16410011
1,3,22.0,Erythema,16410011
2,3,22.0,Skin fissures,16410011
3,6,22.0,Fall,16410011
4,3,22.0,Pruritus,16410011
0,2,22.0,Gastric disorder,16410066
1,5,22.0,Death,16410066
0,6,22.0,Blood creatinine increased,16410067
1,6,22.0,Respiratory tract infection,16410067
2,6,22.0,Myocardial ischaemia,16410067
3,6,22.0,Pulmonary oedema,16410067
4,3,22.0,Ejection fraction decreased,16410067
5,6,22.0,Oedema peripheral,16410067
0,6,22.0,Neuropathy peripheral,16410073
1,1,22.0,Rash,16410073
2,1,22.0,Nausea,16410073
3,6,22.0,Anaemia,16410073
4,1,22.0,Hypertrichosis,16410073
5,6,22.0,Thrombocytopenia,16410073
6,4,22.0,Epistaxis,16410073
7,6,22.0,Herpes simplex,16410073
0,1,22.0,Neutrophil count decreased,16410080
0,1,22.1,Fatigue,16410107
1,1,22.1,Performance status decreased,16410107
2,1,22.1,Palmar-plantar erythrodysaesthesia syndrome,16410107
3,1,22.1,Dysphagia,16410107
4,1,22.1,Hypokalaemia,16410107
5,1,22.1,Diarrhoea,16410107
6,1,22.1,Dysgeusia,16410107
7,1,22.1,Nausea,16410107
8,6,22.1,Dysaesthesia,16410107
9,1,22.1,Febrile neutropenia,16410107
0,3,22.0,Platelet count decreased,16410118
1,6,22.0,Rhinorrhoea,16410118
2,6,22.0,Dizziness,16410118
3,3,22.0,Fatigue,16410118
4,3,22.0,Constipation,16410118
5,6,22.0,Cough,16410118
6,1,22.0,Urinary tract infection,16410118
7,6,22.0,Haemoglobin decreased,16410118
8,6,22.0,Drug ineffective,16410118
9,6,22.0,Pain,16410118
10,6,22.0,Dehydration,16410118
11,6,22.0,Sinusitis,16410118
12,1,22.0,Epistaxis,16410118
13,6,22.0,Insomnia,16410118
14,6,22.0,White blood cell count decreased,16410118
15,6,22.0,Feeling abnormal,16410118
16,3,22.0,Carbohydrate antigen 125 increased,16410118
0,,22.0,Adverse drug reaction,16410168
0,5,22.0,Death,16410197
0,6,22.0,Lung neoplasm malignant,16410219
1,6,22.0,Metastases to central nervous system,16410219
0,2,22.0,Optic ischaemic neuropathy,16410221
0,1,22.0,Large intestine perforation,16410248
0,1,22.0,Ejection fraction decreased,16410256
1,1,22.0,Gastrooesophageal reflux disease,16410256
2,1,22.0,Depression,16410256
0,5,22.0,Death,16410277
0,3,22.0,Dizziness,16410300
1,3,22.0,Fatigue,16410300
2,3,22.0,Nervous system disorder,16410300
3,3,22.0,Paraesthesia,16410300
4,1,22.0,Oedema peripheral,16410300
0,1,22.0,Abdominal pain,16410323
1,1,22.0,Acid peptic disease,16410323
2,3,22.0,Lipase increased,16410323
0,2,22.0,Carbon dioxide increased,16410344
0,,22.0,Death,16410359
0,,22.0,Hospitalisation,16410386
0,3,22.1,Alopecia,16410391
1,3,22.1,Madarosis,16410391
2,3,22.1,Hair colour changes,16410391
3,3,22.1,Hair disorder,16410391
4,3,22.1,Hair texture abnormal,16410391
0,6,22.0,Vomiting,16410401
1,6,22.0,Haemoglobin decreased,16410401
0,6,22.1,Thrombosis,16410411
1,3,22.1,Amnesia,16410411
2,6,22.1,Limb injury,16410411
3,6,22.1,Confusional state,16410411
4,6,22.1,Fatigue,16410411
5,6,22.1,Cardiac disorder,16410411
6,6,22.1,Hand fracture,16410411
7,6,22.1,Feeling abnormal,16410411
8,6,22.1,Malaise,16410411
0,,22.0,Scar,16410427
1,,22.0,Diarrhoea,16410427
0,3,22.0,Anaemia,16410432
1,3,22.0,Bone density abnormal,16410432
2,3,22.0,Dyspnoea,16410432
3,3,22.0,Fatigue,16410432
4,3,22.0,Alopecia,16410432
5,3,22.0,Increased tendency to bruise,16410432
6,3,22.0,Weight increased,16410432
0,6,22.0,Blood glucose increased,16410436
1,6,22.0,Haemoglobin decreased,16410436
2,6,22.0,White blood cell count decreased,16410436
0,6,22.0,Balance disorder,16410498
1,6,22.0,Rash,16410498
2,6,22.0,Dermatitis allergic,16410498
3,6,22.0,Angioedema,16410498
0,,22.0,Flushing,16410563
1,,22.0,Infusion related reaction,16410563
2,,22.0,Muscle spasms,16410563
0,3,22.0,Alopecia,16410574
1,6,22.0,Hair texture abnormal,16410574
2,3,22.0,Madarosis,16410574
3,6,22.0,Hair disorder,16410574
4,6,22.0,Hair colour changes,16410574
0,1,22.0,Vomiting,16410589
1,1,22.0,Pyrexia,16410589
2,1,22.0,Diarrhoea,16410589
0,2,22.0,Dyspnoea,16410604
1,2,22.0,Laryngeal oedema,16410604
2,2,22.0,Rash,16410604
3,2,22.0,Throat tightness,16410604
4,2,22.0,Pruritus,16410604
0,3,22.0,Purpura,16410638
1,3,22.0,Rash vesicular,16410638
2,3,22.0,Rash pruritic,16410638
0,6,22.0,Pulmonary oedema,16410665
1,6,22.0,Dyspnoea,16410665
0,2,22.0,Malaise,16410667
1,2,22.0,Loss of consciousness,16410667
0,3,22.0,Sepsis,16410731
1,3,22.0,Abdominal infection,16410731
2,6,22.0,Dehydration,16410731
3,3,22.0,Fatigue,16410731
0,3,22.0,Phlebitis,16410738
0,,22.0,Condition aggravated,16410753
1,,22.0,Arthralgia,16410753
2,,22.0,Trigger finger,16410753
0,3,22.0,Retinopathy,16410755
0,1,22.0,Posterior reversible encephalopathy syndrome,16410783
0,6,22.0,Muscle spasms,16410807
0,6,22.1,Hepatic function abnormal,16410842
1,5,22.1,Pneumonitis,16410842
2,6,22.1,Tumour lysis syndrome,16410842
3,3,22.1,Hyperbilirubinaemia,16410842
4,1,22.1,Hyperuricaemia,16410842
0,6,22.0,Electrocardiogram T wave inversion,16410880
1,6,22.0,Neutrophil count decreased,16410880
2,1,22.0,Chest pain,16410880
0,1,22.0,Hyperthermia,16411000
1,1,22.0,Oxygen saturation decreased,16411000
2,1,22.0,Hypovolaemia,16411000
0,5,22.0,Interstitial lung disease,16411048
0,1,22.0,Paraesthesia,16411081
0,1,22.0,Osteonecrosis of jaw,16411173
1,1,22.0,Actinomycosis,16411173
2,2,22.0,Paraesthesia,16411173
3,1,22.0,Breath odour,16411173
4,1,22.0,Toxicity to various agents,16411173
0,6,22.0,Product use in unapproved indication,16411179
1,6,22.0,Surgery,16411179
0,1,22.0,Hyperaesthesia,16411184
1,6,22.0,Agitation,16411184
2,1,22.0,Delirium,16411184
0,6,22.0,Loss of consciousness,16411219
0,6,22.0,Stomatitis,16411283
1,6,22.0,Fatigue,16411283
2,6,22.0,Nausea,16411283
3,6,22.0,Dermatitis acneiform,16411283
4,6,22.0,Diarrhoea,16411283
0,6,22.0,Decreased immune responsiveness,16411305
1,6,22.0,Fatigue,16411305
2,6,22.0,Product dose omission,16411305
3,6,22.0,Neuropathy peripheral,16411305
4,6,22.0,Full blood count decreased,16411305
0,6,22.0,Abscess limb,16411311
0,3,22.0,Madarosis,16411340
1,6,22.0,Hair texture abnormal,16411340
2,6,22.0,Hair colour changes,16411340
3,3,22.0,Alopecia,16411340
4,6,22.0,Hair disorder,16411340
0,3,22.0,Diarrhoea,16411352
1,3,22.0,Dry eye,16411352
2,3,22.0,Insomnia,16411352
3,3,22.0,Onychoclasis,16411352
4,3,22.0,Ingrowing nail,16411352
5,1,22.0,Lip dry,16411352
6,1,22.0,Dry mouth,16411352
7,3,22.0,Fatigue,16411352
8,3,22.0,Nail disorder,16411352
9,1,22.0,Dysphonia,16411352
10,3,22.0,Visual impairment,16411352
11,3,22.0,Acne,16411352
12,3,22.0,Alopecia,16411352
13,1,22.0,Decreased appetite,16411352
14,3,22.0,Hair growth abnormal,16411352
15,3,22.0,Constipation,16411352
0,3,22.0,Atrial fibrillation,16411395
1,1,22.0,Neutropenia,16411395
2,1,22.0,Pyrexia,16411395
3,1,22.0,Condition aggravated,16411395
4,1,22.0,Pyelonephritis,16411395
5,1,22.0,Tachycardia,16411395
6,1,22.0,Urinary tract infection,16411395
0,3,22.1,Fatigue,16411415
1,3,22.1,Dysphonia,16411415
2,6,22.1,Abdominal pain upper,16411415
3,3,22.1,Headache,16411415
4,3,22.1,Diarrhoea,16411415
5,6,22.1,Malignant neoplasm progression,16411415
6,3,22.1,Decreased appetite,16411415
7,6,22.1,Blister,16411415
8,6,22.1,Ulcer,16411415
9,6,22.1,Clostridium difficile infection,16411415
10,6,22.1,Dehydration,16411415
11,3,22.1,Arthralgia,16411415
12,3,22.1,Flatulence,16411415
13,2,22.1,Pneumonia,16411415
0,6,22.0,Bone marrow failure,16411459
0,,22.0,Paraesthesia,16411519
1,3,22.0,Neuropathy peripheral,16411519
2,,22.0,Abdominal pain,16411519
3,,22.0,Product use in unapproved indication,16411519
4,,22.0,Back pain,16411519
5,,22.0,Off label use,16411519
0,2,22.0,Headache,16411520
1,3,22.0,Bone marrow failure,16411520
2,6,22.0,Anaemia,16411520
3,6,22.0,Alopecia,16411520
4,3,22.0,Fatigue,16411520
5,6,22.0,Leukopenia,16411520
0,5,22.0,Neoplasm progression,16411581
0,5,22.0,Respiratory distress,16411594
1,5,22.0,Joint stiffness,16411594
2,5,22.0,Dyspnoea,16411594
3,5,22.0,Pyrexia,16411594
4,5,22.0,Disseminated intravascular coagulation,16411594
5,5,22.0,Pulmonary embolism,16411594
6,5,22.0,Granuloma,16411594
7,5,22.0,Cardio-respiratory arrest,16411594
8,5,22.0,Disseminated Bacillus Calmette-Guerin infection,16411594
9,5,22.0,Disorientation,16411594
10,5,22.0,Pneumonia,16411594
11,5,22.0,Delirium,16411594
12,5,22.0,Tubulointerstitial nephritis,16411594
13,5,22.0,Sepsis,16411594
14,5,22.0,Confusional state,16411594
15,5,22.0,Gait disturbance,16411594
16,5,22.0,Cyanosis,16411594
17,5,22.0,Pallor,16411594
18,5,22.0,Vocal cord paralysis,16411594
0,6,22.0,Leukocytosis,16411646
1,6,22.0,Pneumonia,16411646
2,1,22.0,Dyspnoea,16411646
3,6,22.0,Haemoglobin decreased,16411646
0,5,22.0,Interstitial lung disease,16411677
1,3,22.0,Klebsiella test positive,16411677
2,3,22.0,Renal disorder,16411677
3,5,22.0,Pharyngeal cancer,16411677
4,3,22.0,Circulatory collapse,16411677
5,3,22.0,Candida test positive,16411677
6,6,22.0,Condition aggravated,16411677
7,3,22.0,Liver disorder,16411677
0,6,22.0,Osteonecrosis of jaw,16411678
0,1,22.1,Interstitial lung disease,16411681
1,6,22.1,Taste disorder,16411681
0,5,22.0,Sepsis,16411683
0,3,22.0,Castleman^s disease,16411688
0,6,22.1,Asthenia,16411697
1,6,22.1,Depressed mood,16411697
2,3,22.1,Axillary pain,16411697
3,6,22.1,Second primary malignancy,16411697
4,2,22.1,Carotid body tumour,16411697
5,6,22.1,Haematocrit decreased,16411697
6,6,22.1,Headache,16411697
7,6,22.1,Bone pain,16411697
8,6,22.1,Haemoglobin decreased,16411697
0,6,22.0,Interstitial lung disease,16411702
0,2,22.0,Intracranial venous sinus thrombosis,16411708
0,3,22.0,Condition aggravated,16411715
1,6,22.0,Vomiting,16411715
2,3,22.0,Dry mouth,16411715
3,3,22.0,Confusional state,16411715
4,1,22.0,Nausea,16411715
5,3,22.0,Headache,16411715
6,3,22.0,Depressed mood,16411715
7,3,22.0,Dyspepsia,16411715
8,4,22.0,Tachycardia,16411715
9,3,22.0,Incontinence,16411715
10,4,22.0,Lower respiratory tract infection,16411715
11,3,22.0,Dizziness,16411715
12,4,22.0,Supraventricular tachycardia,16411715
13,3,22.0,Dyspnoea,16411715
14,3,22.0,Pneumonia,16411715
15,3,22.0,Malaise,16411715
16,3,22.0,Rash,16411715
0,2,22.0,Nausea,16411772
1,2,22.0,Cough,16411772
2,2,22.0,Rash,16411772
0,1,22.0,Hair texture abnormal,16411794
1,1,22.0,Madarosis,16411794
2,1,22.0,Hair colour changes,16411794
3,1,22.0,Hair disorder,16411794
4,6,22.0,Alopecia,16411794
0,6,22.1,Febrile neutropenia,16411796
1,1,22.1,White blood cell count decreased,16411796
0,1,22.0,Cytopenia,16412010
0,1,22.0,Erythema multiforme,16412137
0,6,22.0,Hypomagnesaemia,16412225
1,6,22.0,Hypokalaemia,16412225
2,1,22.0,Headache,16412225
3,6,22.0,Thirst,16412225
4,6,22.0,Hypocalcaemia,16412225
5,1,22.0,Vomiting,16412225
6,6,22.0,Seasonal allergy,16412225
7,1,22.0,Diarrhoea,16412225
8,6,22.0,Diarrhoea,16412225
9,1,22.0,Dizziness,16412225
10,6,22.0,Fatigue,16412225
11,6,22.0,Abdominal pain,16412225
12,1,22.0,Infection,16412225
13,6,22.0,Decreased appetite,16412225
14,2,22.0,Hyperglycaemia,16412225
15,6,22.0,Dysgeusia,16412225
16,1,22.0,Swelling face,16412225
17,6,22.0,Nausea,16412225
0,3,22.1,Epistaxis,16412230
1,3,22.1,Proteinuria,16412230
2,1,22.1,Nasopharyngitis,16412230
3,1,22.1,Syncope,16412230
4,3,22.1,Neuropathy peripheral,16412230
5,1,22.1,Epistaxis,16412230
6,3,22.1,Constipation,16412230
7,1,22.1,Diarrhoea,16412230
8,3,22.1,Dysphonia,16412230
9,3,22.1,Dysphonia,16412230
10,3,22.1,Respiratory tract infection,16412230
11,3,22.1,Malaise,16412230
12,3,22.1,Haemorrhage,16412230
13,3,22.1,Fatigue,16412230
14,3,22.1,Diarrhoea,16412230
15,3,22.1,Scab,16412230
16,3,22.1,Stomatitis,16412230
17,1,22.1,Anal haemorrhage,16412230
0,3,22.0,Polyneuropathy,16412233
1,1,22.0,Nausea,16412233
2,1,22.0,Leukopenia,16412233
3,1,22.0,Urinary tract infection,16412233
4,1,22.0,Vomiting,16412233
5,1,22.0,Hypertension,16412233
6,1,22.0,Fatigue,16412233
7,1,22.0,Anaemia,16412233
8,1,22.0,Mucosal inflammation,16412233
9,1,22.0,Pyrexia,16412233
0,3,22.0,Balance disorder,16412240
1,3,22.0,Hypertension,16412240
2,3,22.0,Neutropenia,16412240
3,6,22.0,Mouth ulceration,16412240
4,3,22.0,Aphthous ulcer,16412240
5,6,22.0,Joint swelling,16412240
6,6,22.0,Diarrhoea,16412240
7,3,22.0,Dysgeusia,16412240
8,6,22.0,Vomiting,16412240
9,3,22.0,Visual impairment,16412240
10,3,22.0,Dry skin,16412240
11,3,22.0,Anaemia,16412240
12,1,22.0,Nausea,16412240
13,3,22.0,Oedema peripheral,16412240
14,3,22.0,Vision blurred,16412240
15,3,22.0,Blood magnesium abnormal,16412240
16,6,22.0,Weight decreased,16412240
17,3,22.0,Burning sensation,16412240
18,3,22.0,Fatigue,16412240
19,3,22.0,Muscle spasms,16412240
20,1,22.0,Fatigue,16412240
21,6,22.0,Decreased appetite,16412240
0,1,22.0,Small intestinal obstruction,16412246
1,3,22.0,Weight decreased,16412246
2,3,22.0,General physical health deterioration,16412246
3,1,22.0,Urinary tract infection,16412246
4,3,22.0,Thoracic vertebral fracture,16412246
5,1,22.0,Bronchitis,16412246
6,3,22.0,Polyneuropathy,16412246
7,3,22.0,Hyperglycaemia,16412246
8,3,22.0,Cough,16412246
9,1,22.0,Weight increased,16412246
10,3,22.0,International normalised ratio increased,16412246
11,3,22.0,Nausea,16412246
12,3,22.0,Vitamin D deficiency,16412246
13,3,22.0,Decubitus ulcer,16412246
14,1,22.0,Hypomagnesaemia,16412246
15,3,22.0,Decreased appetite,16412246
16,1,22.0,Hypokalaemia,16412246
17,3,22.0,Constipation,16412246
18,3,22.0,Thrombocytopenia,16412246
19,3,22.0,Aphthous ulcer,16412246
0,1,22.1,Neutropenia,16412247
1,3,22.1,Thrombocytopenia,16412247
2,1,22.1,Pyrexia,16412247
3,3,22.1,Blood lactate dehydrogenase increased,16412247
4,1,22.1,Hypersensitivity,16412247
5,3,22.1,General physical health deterioration,16412247
6,3,22.1,Abdominal pain upper,16412247
7,3,22.1,Constipation,16412247
8,3,22.1,C-reactive protein increased,16412247
9,3,22.1,Liver function test increased,16412247
10,3,22.1,Blood bilirubin increased,16412247
0,1,22.0,Panniculitis,16412254
0,1,22.0,Bursitis,16412264
1,6,22.0,Rash,16412264
2,1,22.0,Panniculitis,16412264
0,6,22.0,Prescribed underdose,16412291
1,6,22.0,Malignant neoplasm progression,16412291
0,6,22.0,Breast cancer female,16412395
1,6,22.0,Malignant neoplasm progression,16412395
0,2,22.0,Alanine aminotransferase increased,16412398
1,6,22.0,Aspartate aminotransferase increased,16412398
0,3,22.0,Blindness unilateral,16412451
1,3,22.0,Peroneal nerve palsy,16412451
2,6,22.0,Cerebrovascular accident,16412451
3,3,22.0,Muscular weakness,16412451
0,6,22.0,Palmar-plantar erythrodysaesthesia syndrome,16412476
1,6,22.0,Neutropenia,16412476
2,6,22.0,Metastases to lymph nodes,16412476
3,6,22.0,Metastases to lung,16412476
4,5,22.0,Death,16412476
5,6,22.0,Cardiotoxicity,16412476
6,6,22.0,Metastases to liver,16412476
0,2,22.0,Immune-mediated hepatitis,16412518
1,2,22.0,Abdominal pain,16412518
2,2,22.0,Haematochezia,16412518
3,2,22.0,Diarrhoea,16412518
4,2,22.0,Abdominal pain upper,16412518
5,6,22.0,Respiratory tract infection,16412518
6,2,22.0,Pyrexia,16412518
0,1,22.0,Skin disorder,16412618
0,2,22.0,Colitis,16412632
1,2,22.0,Interstitial lung disease,16412632
0,1,22.0,Pneumatosis intestinalis,16412683
0,3,22.0,Perineal pain,16412696
1,1,22.0,Pain,16412696
2,2,22.0,Malaise,16412696
3,3,22.0,Decreased appetite,16412696
4,1,22.0,Neuropathy peripheral,16412696
5,2,22.0,Dyspnoea,16412696
6,2,22.0,Weight decreased,16412696
7,1,22.0,Seizure,16412696
8,1,22.0,Constipation,16412696
9,1,22.0,Vomiting,16412696
10,2,22.0,Fatigue,16412696
11,2,22.0,Anaemia,16412696
12,1,22.0,Transferrin saturation decreased,16412696
13,2,22.0,Haematuria,16412696
14,1,22.0,Haematoma infection,16412696
15,3,22.0,Chronic kidney disease,16412696
16,1,22.0,Nausea,16412696
0,2,22.0,Leukopenia,16412700
1,2,22.0,Neutropenia,16412700
0,6,22.1,Intentional product use issue,16412741
1,2,22.1,Mania,16412741
2,4,22.1,Leukoencephalopathy,16412741
0,1,22.1,Lipase increased,16412769
0,6,22.0,Arthralgia,16412800
1,6,22.0,Visual impairment,16412800
2,6,22.0,Joint swelling,16412800
3,6,22.0,Eye disorder,16412800
0,5,22.1,Bronchopulmonary aspergillosis,16412851
1,5,22.1,Autoimmune colitis,16412851
2,1,22.1,Interstitial lung disease,16412851
0,6,22.0,Ascites,16412858
1,5,22.0,Malignant neoplasm progression,16412858
0,1,22.1,Hypoaesthesia,16412885
1,1,22.1,Paraesthesia,16412885
2,1,22.1,Polyneuropathy,16412885
0,2,22.1,Electrolyte imbalance,16412892
1,1,22.1,Inappropriate antidiuretic hormone secretion,16412892
2,1,22.1,General physical health deterioration,16412892
0,3,22.0,Polyneuropathy,16412900
0,3,22.1,Thrombocytosis,16412929
1,1,22.1,Back pain,16412929
2,6,22.1,Nausea,16412929
3,3,22.1,Constipation,16412929
4,3,22.1,Restlessness,16412929
5,3,22.1,Dizziness,16412929
6,3,22.1,Paraesthesia,16412929
7,3,22.1,Fatigue,16412929
8,2,22.1,Electrocardiogram QT prolonged,16412929
9,6,22.1,Weight decreased,16412929
10,3,22.1,Taste disorder,16412929
11,3,22.1,Pruritus,16412929
12,3,22.1,Abdominal pain upper,16412929
0,4,22.0,Vertigo,16412954
1,4,22.0,Fall,16412954
2,4,22.0,Vomiting,16412954
0,6,22.0,Jaundice,16412974
1,6,22.0,Transaminases increased,16412974
2,6,22.0,Chromaturia,16412974
0,2,22.0,Cerebral ischaemia,16413027
0,2,22.0,Constipation,16413033
1,6,22.0,Mucosal inflammation,16413033
2,6,22.0,Ascites,16413033
3,6,22.0,Palmar-plantar erythrodysaesthesia syndrome,16413033
4,6,22.0,Neutrophil count decreased,16413033
5,6,22.0,Neutropenia,16413033
6,2,22.0,Abdominal distension,16413033
7,6,22.0,Decreased appetite,16413033
8,2,22.0,Pleural effusion,16413033
9,6,22.0,Marasmus,16413033
10,2,22.0,Gastrointestinal wall thickening,16413033
11,2,22.0,Hypophagia,16413033
0,6,22.0,Heart rate increased,16413051
0,6,22.0,Therapeutic product effect decreased,16413074
1,3,22.0,Device related infection,16413074
2,6,22.0,Intestinal obstruction,16413074
3,6,22.0,Cholelithiasis,16413074
4,6,22.0,Ill-defined disorder,16413074
5,2,22.0,Intestinal obstruction,16413074
6,6,22.0,Cholecystitis chronic,16413074
0,6,22.1,Diarrhoea,16413084
1,6,22.1,Gastrointestinal ulcer,16413084
2,1,22.1,Diarrhoea,16413084
3,6,22.1,Feeding disorder,16413084
4,2,22.1,Stomatitis,16413084
5,6,22.1,Arthritis,16413084
6,6,22.1,Asthenia,16413084
7,3,22.1,Urticaria,16413084
8,6,22.1,Dizziness,16413084
9,6,22.1,Insomnia,16413084
10,6,22.1,Nasopharyngitis,16413084
11,6,22.1,Mucosal inflammation,16413084
0,5,22.0,Disease progression,16413102
0,1,22.0,Dyspnoea,16413121
1,1,22.0,Vomiting,16413121
2,1,22.0,Nausea,16413121
3,1,22.0,Sinus tachycardia,16413121
4,1,22.0,Abdominal pain,16413121
0,2,22.0,Pneumatosis intestinalis,16413161
1,1,22.0,Aortic thrombosis,16413161
0,1,22.0,Infusion related reaction,16413187
1,1,22.0,Seizure,16413187
2,6,22.0,Akathisia,16413187
0,6,22.0,Anaemia,16413222
1,6,22.0,Performance status decreased,16413222
2,2,22.0,Aplasia pure red cell,16413222
0,1,22.0,Bicytopenia,16413236
0,6,22.0,Diffuse alveolar damage,16413379
0,1,22.0,Interstitial lung disease,16413411
0,6,22.0,Intentional product use issue,16413439
1,5,22.0,Death,16413439
0,1,22.0,Lumbar vertebral fracture,16413444
0,6,22.0,Stomatitis,16413521
1,6,22.0,Vomiting,16413521
0,1,22.0,Colitis,16413582
1,6,22.0,Haematochezia,16413582
0,6,22.0,Lung infection,16413632
0,3,22.0,Gait disturbance,16413651
1,3,22.0,Muscular weakness,16413651
0,6,22.0,Immune-mediated adverse reaction,16413663
0,2,22.0,Mononeuropathy multiplex,16413677
1,6,22.0,Diarrhoea,16413677
0,5,22.0,Death,16413697
0,6,22.0,Pyrexia,16413839
0,3,22.0,Pneumonia,16413856
1,3,22.0,Febrile neutropenia,16413856
2,6,22.0,Haematotoxicity,16413856
0,3,22.1,Malaise,16413867
1,1,22.1,Rash,16413867
2,3,22.1,Peripheral swelling,16413867
3,2,22.1,Dyspnoea,16413867
4,3,22.1,Decreased appetite,16413867
5,3,22.1,Joint swelling,16413867
6,6,22.1,Off label use,16413867
7,3,22.1,Diarrhoea,16413867
8,6,22.1,Rash,16413867
0,1,22.0,Hypertensive crisis,16413901
0,1,22.0,Pneumonia,16413978
1,1,22.0,Injection site cellulitis,16413978
0,1,22.0,Visual impairment,16414073
1,1,22.0,Joint swelling,16414073
2,1,22.0,Blindness,16414073
3,1,22.0,Eye haemorrhage,16414073
4,1,22.0,Peripheral swelling,16414073
5,1,22.0,Vision blurred,16414073
0,5,22.0,Hepatitis,16414080
1,5,22.0,Septic shock,16414080
2,3,22.0,General physical health deterioration,16414080
0,5,22.0,Metastases to lung,16414088
0,3,22.0,Weight decreased,16414145
1,3,22.0,Nausea,16414145
2,3,22.0,Diarrhoea,16414145
3,3,22.0,Hyperkeratosis,16414145
4,3,22.0,Decreased appetite,16414145
5,3,22.0,Anaemia,16414145
6,3,22.0,Asthenia,16414145
7,3,22.0,Vomiting,16414145
0,1,22.0,Diverticulitis,16414159
0,1,22.0,Cerebrovascular accident,16414221
1,6,22.0,Malignant neoplasm progression,16414221
2,6,22.0,Prostatic specific antigen increased,16414221
3,6,22.0,Drug ineffective,16414221
0,2,22.0,Tubulointerstitial nephritis,16414291
0,6,22.0,Fibroma,16414306
0,6,22.0,Malignant neoplasm progression,16414324
1,6,22.0,Drug resistance,16414324
2,6,22.0,Acquired gene mutation,16414324
0,3,22.1,Pericardial effusion,16414358
1,1,22.1,White blood cell count decreased,16414358
2,1,22.1,Neutrophil count decreased,16414358
3,1,22.1,Hiccups,16414358
4,1,22.1,Decreased appetite,16414358
0,1,22.0,Fatigue,16414362
0,6,22.1,Insomnia,16414387
1,6,22.1,Peripheral coldness,16414387
2,6,22.1,Deafness,16414387
3,6,22.1,Irritability,16414387
4,6,22.1,Underweight,16414387
5,6,22.1,Stomatitis,16414387
6,1,22.1,Asthenia,16414387
7,6,22.1,Oral candidiasis,16414387
8,6,22.1,Coronary artery occlusion,16414387
9,3,22.1,Hypertension,16414387
0,6,22.0,Neutropenia,16414405
1,6,22.0,Depressed mood,16414405
2,6,22.0,Metastases to liver,16414405
3,6,22.0,Malignant neoplasm progression,16414405
4,6,22.0,Gallbladder polyp,16414405
5,6,22.0,Weight increased,16414405
0,1,22.0,Cardiac failure,16414406
0,2,22.0,Oedema peripheral,16414407
1,6,22.0,Infection,16414407
2,6,22.0,Malaise,16414407
3,1,22.0,Nasopharyngitis,16414407
4,2,22.0,Fluid overload,16414407
5,2,22.0,Gait disturbance,16414407
6,3,22.0,Generalised oedema,16414407
7,1,22.0,Dyspnoea,16414407
0,1,22.0,Bone marrow failure,16414411
0,2,22.1,Rectal abscess,16414469
0,5,22.1,Death,16414499
1,6,22.1,Pleural effusion,16414499
0,2,22.0,Interstitial lung disease,16414523
1,6,22.0,Pleural effusion,16414523
2,6,22.0,Neutrophil count decreased,16414523
0,5,22.0,Disease progression,16414529
0,,22.0,Acute myocardial infarction,16414550
0,1,22.0,Neutropenia,16414553
1,1,22.0,Aphthous ulcer,16414553
2,1,22.0,Thrombocytopenia,16414553
0,1,22.1,Neutropenia,16414566
1,3,22.1,Diarrhoea,16414566
2,1,22.1,Leukopenia,16414566
3,3,22.1,Stomatitis,16414566
4,3,22.1,Abdominal pain,16414566
5,3,22.1,Intertrigo,16414566
6,3,22.1,Rash erythematous,16414566
7,3,22.1,Hypomagnesaemia,16414566
8,3,22.1,Nausea,16414566
0,5,22.0,Death,16414582
1,3,22.0,Urinary tract infection,16414582
2,6,22.0,Product dose omission,16414582
3,3,22.0,Internal haemorrhage,16414582
4,3,22.0,Rectal haemorrhage,16414582
0,5,22.0,Death,16414589
0,3,22.0,Metastases to liver,16414605
1,3,22.0,Venoocclusive liver disease,16414605
0,3,22.0,Venoocclusive liver disease,16414606
1,3,22.0,Metastases to lymph nodes,16414606
2,3,22.0,IIIrd nerve paralysis,16414606
3,5,22.0,Hypopnoea,16414606
0,1,22.0,Biliary fistula,16414608
0,2,22.0,Hypertransaminasaemia,16414611
0,,22.0,Neuropathy peripheral,16414617
0,,22.0,Gastrooesophageal reflux disease,16414622
1,,22.0,Blood cholesterol increased,16414622
0,6,22.0,Back pain,16414624
1,6,22.0,Weight decreased,16414624
2,6,22.0,Asthenia,16414624
3,6,22.0,Dyspnoea,16414624
4,6,22.0,Hypotension,16414624
5,6,22.0,Decreased appetite,16414624
6,6,22.0,Malignant ascites,16414624
7,6,22.0,Biliary drainage,16414624
8,6,22.0,Musculoskeletal pain,16414624
9,6,22.0,Malnutrition,16414624
10,6,22.0,Malaise,16414624
11,5,22.0,Death,16414624
12,6,22.0,Fatigue,16414624
13,6,22.0,Gait disturbance,16414624
14,6,22.0,Diarrhoea,16414624
0,,22.0,Dysphonia,16414627
1,,22.0,Headache,16414627
0,,22.0,Death,16414635
0,3,22.0,Pericardial effusion,16414649
1,3,22.0,Neoplasm progression,16414649
2,1,22.0,Pneumonia,16414649
0,5,22.0,Death,16414652
0,,22.0,Gastrointestinal haemorrhage,16414667
1,,22.0,Necrosis,16414667
0,,22.0,Hospice care,16414695
0,5,22.0,Death,16414715
1,3,22.0,Gastric haemorrhage,16414715
2,3,22.0,Abdominal distension,16414715
3,3,22.0,Hepatic function abnormal,16414715
4,,22.0,Off label use,16414715
0,5,22.0,Cardiotoxicity,16414718
0,1,22.0,Hypotension,16414722
1,1,22.0,Flushing,16414722
2,1,22.0,Hypersensitivity,16414722
3,1,22.0,Oedema,16414722
4,1,22.0,Rash,16414722
0,1,22.0,Amnesia,16414725
1,3,22.0,Nausea,16414725
2,,22.0,Arthralgia,16414725
3,1,22.0,Palmar-plantar erythrodysaesthesia syndrome,16414725
4,,22.0,Off label use,16414725
5,1,22.0,Dehydration,16414725
6,6,22.0,Product dose omission,16414725
7,3,22.0,Arthralgia,16414725
0,1,22.0,Prostatitis,16414728
0,6,22.0,White blood cell count decreased,16414735
1,6,22.0,Neutropenia,16414735
2,6,22.0,Carbohydrate antigen 15-3 increased,16414735
0,3,22.1,Madarosis,16414745
1,3,22.1,Alopecia,16414745
0,6,22.0,Upper limb fracture,16414751
1,2,22.0,Bacterial infection,16414751
2,6,22.0,Fall,16414751
3,6,22.0,Vomiting,16414751
0,6,22.0,Increased upper airway secretion,16414756
1,6,22.0,Pruritus,16414756
2,6,22.0,Foreign body sensation in eyes,16414756
0,3,22.1,Hair texture abnormal,16414771
1,3,22.1,Hair colour changes,16414771
2,3,22.1,Alopecia,16414771
3,3,22.1,Madarosis,16414771
4,3,22.1,Hair disorder,16414771
0,3,22.1,Hair texture abnormal,16414775
1,3,22.1,Alopecia,16414775
2,3,22.1,Hair disorder,16414775
3,3,22.1,Madarosis,16414775
4,3,22.1,Hair colour changes,16414775
0,,22.0,Death,16414797
0,3,22.1,Madarosis,16414798
1,3,22.1,Alopecia,16414798
2,3,22.1,Hair colour changes,16414798
3,3,22.1,Hair texture abnormal,16414798
4,3,22.1,Hair disorder,16414798
0,6,22.0,Vomiting,16414809
1,6,22.0,Diarrhoea,16414809
2,6,22.0,Neutrophil count abnormal,16414809
0,6,22.0,Inappropriate schedule of product administration,16414878
1,6,22.0,Myasthenia gravis,16414878
2,6,22.0,Myasthenia gravis crisis,16414878
0,2,22.0,Addison^s disease,16414892
1,1,22.0,Sepsis,16414892
2,1,22.0,Acute kidney injury,16414892
3,6,22.0,Liver abscess,16414892
0,6,22.1,Nasopharyngitis,16414942
1,6,22.1,Product dose omission,16414942
2,1,22.1,Malaise,16414942
3,1,22.1,Neoplasm progression,16414942
4,3,22.1,Fatigue,16414942
5,3,22.1,Paraesthesia,16414942
6,1,22.1,Hepatic enzyme increased,16414942
7,6,22.1,Infection,16414942
8,6,22.1,Asthenia,16414942
9,6,22.1,Headache,16414942
10,1,22.1,Memory impairment,16414942
0,1,22.1,Constipation,16414957
1,5,22.1,Intestinal perforation,16414957
2,6,22.1,Bone pain,16414957
3,6,22.1,Weight decreased,16414957
4,5,22.1,Pneumonia,16414957
5,1,22.1,Diarrhoea,16414957
6,6,22.1,Nausea,16414957
7,2,22.1,Decreased appetite,16414957
0,3,22.1,Hair colour changes,16415136
1,3,22.1,Alopecia,16415136
2,3,22.1,Hair disorder,16415136
3,3,22.1,Hair texture abnormal,16415136
4,3,22.1,Madarosis,16415136
0,3,22.1,Hair colour changes,16415144
1,3,22.1,Alopecia,16415144
2,3,22.1,Hair texture abnormal,16415144
3,3,22.1,Madarosis,16415144
4,3,22.1,Hair disorder,16415144
0,3,22.1,Fatigue,16415152
1,2,22.1,Nausea,16415152
2,2,22.1,Dyspepsia,16415152
3,3,22.1,Hot flush,16415152
4,2,22.1,Leukopenia,16415152
5,6,22.1,Blood count abnormal,16415152
6,3,22.1,White blood cell count decreased,16415152
0,3,22.0,Alopecia,16415154
0,3,22.1,Hair texture abnormal,16415168
1,3,22.1,Madarosis,16415168
2,3,22.1,Alopecia,16415168
3,3,22.1,Hair colour changes,16415168
4,3,22.1,Hair disorder,16415168
0,,22.0,Death,16415180
0,6,22.0,Neoplasm progression,16415181
0,1,22.1,White blood cell count decreased,16415207
1,6,22.1,Fatigue,16415207
2,3,22.1,Alopecia,16415207
0,,22.0,Disease progression,16415285
0,6,22.0,Psychological trauma,16415287
1,6,22.0,Anxiety,16415287
2,2,22.0,Alopecia,16415287
3,6,22.0,Impaired quality of life,16415287
4,6,22.0,Pain,16415287
5,6,22.0,Emotional distress,16415287
0,6,22.0,Psychological trauma,16415289
1,2,22.0,Alopecia,16415289
0,2,22.0,Alopecia,16415294
0,,22.0,Hospice care,16415303
0,6,22.0,Vesical fistula,16415315
1,6,22.0,Fatigue,16415315
2,6,22.0,Anal abscess,16415315
0,6,22.0,Product dose omission,16415346
1,3,22.0,Pollakiuria,16415346
2,3,22.0,Micturition urgency,16415346
0,1,22.0,Hypokalaemia,16415363
1,1,22.0,Hyponatraemia,16415363
0,6,22.0,Psychological trauma,16415374
1,2,22.0,Alopecia,16415374
0,6,22.0,Psychological trauma,16415377
1,3,22.0,Alopecia,16415377
0,3,22.0,Alopecia,16415378
0,2,22.0,Alopecia,16415381
0,2,22.0,Alopecia,16415387
1,6,22.0,Psychological trauma,16415387
0,2,22.1,Alopecia,16415401
1,6,22.1,Psychological trauma,16415401
0,6,22.0,Psychological trauma,16415408
1,2,22.0,Alopecia,16415408
0,3,22.1,Alopecia,16415417
1,6,22.1,Psychological trauma,16415417
0,6,22.0,Psychological trauma,16415423
1,2,22.0,Alopecia,16415423
0,2,22.0,Alopecia,16415441
1,6,22.0,Psychological trauma,16415441
0,,22.0,Disease progression,16415448
0,3,22.1,Alopecia,16415456
1,6,22.1,Psychological trauma,16415456
0,3,22.1,Alopecia,16415457
0,6,22.0,Neutropenia,16415463
0,,22.0,Rash,16415486
1,,22.0,Platelet count decreased,16415486
2,,22.0,Fatigue,16415486
3,,22.0,Epistaxis,16415486
0,3,22.1,Alopecia,16415539
0,1,22.0,Inappropriate schedule of product administration,16415851
1,,22.0,Off label use,16415851
0,1,22.0,Proteinuria,16416017
1,2,22.0,Hypertension,16416017
0,2,22.0,Transurethral prostatectomy,16416066
0,3,22.0,Alopecia,16416067
1,3,22.0,Hair injury,16416067
0,6,22.0,Pain in extremity,16416068
1,6,22.0,Feeling abnormal,16416068
2,2,22.0,Hot flush,16416068
0,6,22.0,Tumour pseudoprogression,16416090
0,2,22.0,Paraesthesia,16416148
1,2,22.0,Asthenia,16416148
2,2,22.0,Skin fissures,16416148
3,2,22.0,Vomiting,16416148
0,3,22.0,Hyperglycaemia,16416159
0,2,22.0,Anaemia,16416164
1,2,22.0,Hypertransaminasaemia,16416164
0,1,22.0,Cardiac failure,16416174
1,6,22.0,Hypertension,16416174
2,2,22.0,Depression,16416174
3,3,22.0,Dyspepsia,16416174
4,1,22.0,Dry skin,16416174
5,1,22.0,Cardiovascular disorder,16416174
6,1,22.0,Fatigue,16416174
7,1,22.0,Pyrexia,16416174
8,1,22.0,Injection site pruritus,16416174
9,1,22.0,Injection site erythema,16416174
10,1,22.0,C-reactive protein increased,16416174
11,1,22.0,Dizziness,16416174
12,1,22.0,Dyspnoea,16416174
13,1,22.0,General physical health deterioration,16416174
14,1,22.0,Tinnitus,16416174
15,1,22.0,Rash,16416174
16,2,22.0,Blood pressure increased,16416174
0,1,22.0,Dermatitis,16416180
0,5,22.0,Hypotension,16416194
1,5,22.0,Septic shock,16416194
2,5,22.0,Multiple organ dysfunction syndrome,16416194
3,5,22.0,Pulmonary sepsis,16416194
0,1,22.0,Mucosal inflammation,16416198
1,2,22.0,Pericardial effusion,16416198
2,2,22.0,Erythema,16416198
0,1,22.0,Mitral valve incompetence,16416199
1,1,22.0,Left ventricular dysfunction,16416199
0,2,22.0,Mitral valve incompetence,16416200
1,3,22.0,Aortic valve incompetence,16416200
2,1,22.0,Pneumonia,16416200
3,3,22.0,Paraesthesia,16416200
4,1,22.0,Tachyarrhythmia,16416200
5,1,22.0,Epistaxis,16416200
6,1,22.0,Acute respiratory failure,16416200
7,1,22.0,Multi-organ disorder,16416200
8,6,22.0,Atrial fibrillation,16416200
9,1,22.0,Septic shock,16416200
10,1,22.0,Acute respiratory distress syndrome,16416200
11,1,22.0,Sepsis,16416200
12,3,22.0,Dizziness,16416200
13,3,22.0,Lacrimation increased,16416200
14,1,22.0,Dyspnoea,16416200
15,1,22.0,Cardiac failure,16416200
16,1,22.0,General physical health deterioration,16416200
17,1,22.0,Erythema,16416200
18,1,22.0,Tricuspid valve incompetence,16416200
19,1,22.0,Electrolyte imbalance,16416200
0,3,22.0,Ejection fraction decreased,16416202
1,5,22.0,Malignant neoplasm progression,16416202
2,5,22.0,Respiratory failure,16416202
3,5,22.0,Cardiac failure,16416202
4,5,22.0,Atrial fibrillation,16416202
0,1,22.0,Arrhythmia,16416203
1,3,22.0,Spinal pain,16416203
2,1,22.0,Glossodynia,16416203
3,1,22.0,Injection site pain,16416203
4,3,22.0,Dizziness,16416203
5,3,22.0,Constipation,16416203
6,3,22.0,Visual impairment,16416203
7,1,22.0,Food aversion,16416203
8,1,22.0,Muscle tightness,16416203
9,1,22.0,Nail discolouration,16416203
10,3,22.0,Skin laceration,16416203
11,3,22.0,Haematoma,16416203
12,1,22.0,Cough,16416203
13,1,22.0,Oedema,16416203
14,3,22.0,Nail ridging,16416203
15,1,22.0,Gingival bleeding,16416203
16,1,22.0,Injection site erythema,16416203
17,3,22.0,Arthralgia,16416203
18,3,22.0,Dry skin,16416203
0,2,22.0,No adverse event,16416240
0,1,22.0,Pyrexia,16416242
1,6,22.0,Pneumonia aspiration,16416242
0,1,22.0,Cardiac failure,16416248
0,,22.0,Hepatic cancer,16416261
1,,22.0,Tumour invasion,16416261
0,6,22.0,Cerebrovascular accident,16416275
0,1,22.0,Adverse event,16416281
1,1,22.0,Vomiting,16416281
2,6,22.0,Drug titration error,16416281
3,6,22.0,Pancytopenia,16416281
4,1,22.0,Neutrophil count decreased,16416281
5,1,22.0,Migraine,16416281
6,6,22.0,Nausea,16416281
7,1,22.0,Thrombocytopenia,16416281
8,6,22.0,Constipation,16416281
9,1,22.0,White blood cell count decreased,16416281
10,1,22.0,Endodontic procedure,16416281
11,6,22.0,Blood bilirubin increased,16416281
12,1,22.0,Drug intolerance,16416281
13,1,22.0,Neutrophil count decreased,16416281
14,1,22.0,Thrombocytopenia,16416281
15,1,22.0,Thrombocytopenia,16416281
16,1,22.0,Headache,16416281
17,6,22.0,Haemoglobin decreased,16416281
18,1,22.0,Emotional distress,16416281
19,1,22.0,White blood cell count decreased,16416281
20,6,22.0,Haematocrit decreased,16416281
0,1,22.1,Pericardial effusion,16416298
0,3,22.0,Osteomyelitis,16416323
1,3,22.0,Fractured sacrum,16416323
0,1,22.0,Breast reconstruction,16416388
1,1,22.0,Central venous catheter removal,16416388
2,2,22.0,Diarrhoea,16416388
0,6,22.0,Agitation,16416438
1,6,22.0,Confusional state,16416438
0,2,22.0,Tubulointerstitial nephritis,16416443
0,1,22.0,Respiratory tract infection,16416491
0,5,22.0,Death,16416497
1,6,22.0,Pyrexia,16416497
0,2,22.0,Sjogren^s syndrome,16416610
0,2,22.0,Delirium,16416630
1,2,22.0,Aggression,16416630
2,6,22.0,Hypercholesterolaemia,16416630
3,6,22.0,Hypertriglyceridaemia,16416630
0,6,22.0,Disseminated intravascular coagulation,16416679
1,1,22.0,Haemophagocytic lymphohistiocytosis,16416679
0,3,22.0,Decreased appetite,16416711
1,5,22.0,General physical health deterioration,16416711
0,1,22.0,Haematotoxicity,16416716
1,6,22.0,Off label use,16416716
2,6,22.0,Product use in unapproved indication,16416716
0,6,22.0,Brain neoplasm,16416757
0,6,22.0,Carcinoembryonic antigen increased,16416785
1,6,22.0,Carbohydrate antigen 15-3 increased,16416785
0,1,22.1,Sepsis,16416795
0,6,22.0,Neoplasm progression,16416796
0,2,22.0,Agranulocytosis,16416800
1,2,22.0,Stomatitis,16416800
2,1,22.0,Pyrexia,16416800
0,1,22.0,Musculoskeletal chest pain,16416808
1,1,22.0,Pain in extremity,16416808
2,1,22.0,Bone lesion,16416808
0,5,22.1,Death,16416818
0,6,22.0,Product use in unapproved indication,16416853
1,6,22.0,Back pain,16416853
2,6,22.0,Decreased appetite,16416853
3,3,22.0,Abdominal pain lower,16416853
4,6,22.0,Drug ineffective for unapproved indication,16416853
5,2,22.0,Blister,16416853
6,6,22.0,Abdominal discomfort,16416853
7,3,22.0,Pain in extremity,16416853
8,6,22.0,Hypersensitivity,16416853
9,6,22.0,Scar,16416853
0,3,22.0,Pain in extremity,16416855
1,6,22.0,Scar,16416855
2,2,22.0,Blister,16416855
3,6,22.0,Hypersensitivity,16416855
4,6,22.0,Product use in unapproved indication,16416855
5,6,22.0,Drug ineffective for unapproved indication,16416855
6,6,22.0,Decreased appetite,16416855
7,3,22.0,Abdominal pain lower,16416855
8,6,22.0,Abdominal discomfort,16416855
9,6,22.0,Back pain,16416855
0,1,22.0,Febrile neutropenia,16416871
1,1,22.0,Listeriosis,16416871
0,5,22.0,Haemoptysis,16416879
1,6,22.0,Liver injury,16416879
2,5,22.0,Sepsis,16416879
3,5,22.0,Pyrexia,16416879
4,6,22.0,White blood cell count decreased,16416879
5,5,22.0,Coma,16416879
6,6,22.0,Hepatic enzyme increased,16416879
7,5,22.0,Disseminated intravascular coagulation,16416879
8,5,22.0,Lethargy,16416879
9,5,22.0,Rash generalised,16416879
10,6,22.0,Platelet count decreased,16416879
11,6,22.0,Blood fibrinogen decreased,16416879
12,5,22.0,Disseminated Bacillus Calmette-Guerin infection,16416879
13,5,22.0,Urothelium erosion,16416879
14,5,22.0,Cardio-respiratory arrest,16416879
0,1,22.0,Disseminated Bacillus Calmette-Guerin infection,16416880
1,1,22.0,Pyrexia,16416880
2,1,22.0,Suprapubic pain,16416880
3,1,22.0,Mental status changes,16416880
4,1,22.0,Sepsis,16416880
5,1,22.0,Chills,16416880
6,1,22.0,Hypotension,16416880
7,1,22.0,Jaundice cholestatic,16416880
8,1,22.0,Disseminated intravascular coagulation,16416880
0,5,22.0,Disseminated Bacillus Calmette-Guerin infection,16416882
1,5,22.0,Urothelium erosion,16416882
2,5,22.0,Mental status changes,16416882
3,5,22.0,Asthenia,16416882
4,5,22.0,Sepsis,16416882
5,5,22.0,Pyrexia,16416882
0,1,22.0,Urinary tract infection,16416884
1,1,22.0,Pain,16416884
2,1,22.0,Urinary tract infection,16416884
0,6,22.0,Malaise,16417004
1,6,22.0,Gingival disorder,16417004
2,6,22.0,Gastric disorder,16417004
3,6,22.0,Diabetes mellitus,16417004
0,6,22.1,Pulmonary oedema,16417011
1,6,22.1,Dizziness,16417011
2,6,22.1,Dyspnoea,16417011
3,3,22.1,Asthenia,16417011
4,3,22.1,Cognitive disorder,16417011
5,3,22.1,Food craving,16417011
6,3,22.1,Taste disorder,16417011
7,1,22.1,Deep vein thrombosis,16417011
8,6,22.1,Neuropathy peripheral,16417011
9,3,22.1,Hypoaesthesia,16417011
10,3,22.1,Sluggishness,16417011
11,6,22.1,Tremor,16417011
12,1,22.1,Cough,16417011
13,6,22.1,Peripheral swelling,16417011
14,6,22.1,Faeces hard,16417011
15,3,22.1,Dyspnoea exertional,16417011
16,1,22.1,Blood pressure increased,16417011
17,3,22.1,Heart valve incompetence,16417011
18,3,22.1,Visual impairment,16417011
19,6,22.1,Emotional distress,16417011
20,6,22.1,Gait disturbance,16417011
21,3,22.1,Musculoskeletal stiffness,16417011
22,1,22.1,Appetite disorder,16417011
23,1,22.1,Chest pain,16417011
24,1,22.1,Constipation,16417011
25,6,22.1,Food poisoning,16417011
26,3,22.1,Productive cough,16417011
27,3,22.1,Nausea,16417011
28,3,22.1,Haemoglobin decreased,16417011
29,3,22.1,Balance disorder,16417011
30,6,22.1,Blood cholesterol decreased,16417011
31,2,22.1,Weight decreased,16417011
32,1,22.1,Decreased appetite,16417011
33,6,22.1,Abdominal rigidity,16417011
34,1,22.1,Myalgia,16417011
35,6,22.1,Abdominal pain,16417011
36,6,22.1,Vomiting,16417011
37,1,22.1,Dehydration,16417011
38,3,22.1,Fatigue,16417011
39,6,22.1,Paraesthesia,16417011
0,3,22.0,Alopecia,16417050
0,1,22.0,Bone neoplasm,16417107
1,1,22.0,Thrombosis,16417107
2,1,22.0,Lymphoma,16417107
3,1,22.0,Prostatic specific antigen increased,16417107
4,1,22.0,Fatigue,16417107
5,1,22.0,Poor venous access,16417107
6,1,22.0,Constipation,16417107
7,1,22.0,Dry skin,16417107
8,1,22.0,Mobility decreased,16417107
9,1,22.0,Pain,16417107
10,1,22.0,Oedema peripheral,16417107
11,1,22.0,Blood pressure systolic increased,16417107
12,1,22.0,Deep vein thrombosis,16417107
13,1,22.0,Stenosis,16417107
0,6,22.0,Necrosis,16417108
0,1,22.0,Anaphylactic shock,16417109
0,6,22.0,Off label use,16417140
1,5,22.0,Encephalitis,16417140
2,6,22.0,Drug effective for unapproved indication,16417140
0,3,22.0,Neutropenia,16417147
0,3,22.1,White blood cell count decreased,16417186
1,3,22.1,Platelet count decreased,16417186
2,3,22.1,Neutrophil count decreased,16417186
3,3,22.1,Red blood cell count decreased,16417186
4,1,22.1,Stomatitis,16417186
0,3,22.1,Alopecia,16417187
0,2,22.0,Abdominal discomfort,16417188
1,1,22.0,Nausea,16417188
2,6,22.0,Constipation,16417188
0,3,22.0,Alopecia,16417203
1,6,22.0,Condition aggravated,16417203
